166 related articles for article (PubMed ID: 27834301)
1. Improvement in insulin sensitivity following intensive insulin therapy and association of glucagon with long-term diabetes remission.
Zhang B; Chen YY; Yang ZJ; Wang X; Li GW
J Int Med Res; 2016 Dec; 44(6):1543-1550. PubMed ID: 27834301
[TBL] [Abstract][Full Text] [Related]
2. Effects of short-term intensive glycemic control on insulin, glucagon, and glucagon-like peptide-1 secretion in patients with Type 2 diabetes.
Shimodaira M; Muroya Y; Kumagai N; Tsuzawa K; Honda K
J Endocrinol Invest; 2013 Oct; 36(9):734-8. PubMed ID: 23580083
[TBL] [Abstract][Full Text] [Related]
3. Effect of Short-term Intensive Insulin Therapy on Post-challenge Hyperglucagonemia in Early Type 2 Diabetes.
Kramer CK; Zinman B; Choi H; Retnakaran R
J Clin Endocrinol Metab; 2015 Aug; 100(8):2987-95. PubMed ID: 26079776
[TBL] [Abstract][Full Text] [Related]
4. Determinants of reversibility of β-cell dysfunction in response to short-term intensive insulin therapy in patients with early type 2 diabetes.
Kramer CK; Choi H; Zinman B; Retnakaran R
Am J Physiol Endocrinol Metab; 2013 Dec; 305(11):E1398-407. PubMed ID: 24129396
[TBL] [Abstract][Full Text] [Related]
5. Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function.
Li Y; Xu W; Liao Z; Yao B; Chen X; Huang Z; Hu G; Weng J
Diabetes Care; 2004 Nov; 27(11):2597-602. PubMed ID: 15504992
[TBL] [Abstract][Full Text] [Related]
6. Insulin requirement profiles of short-term intensive insulin therapy in patients with newly diagnosed type 2 diabetes and its association with long-term glycemic remission.
Liu L; Ke W; Wan X; Zhang P; Cao X; Deng W; Li Y
Diabetes Res Clin Pract; 2015 May; 108(2):250-7. PubMed ID: 25765670
[TBL] [Abstract][Full Text] [Related]
7. Remission of hyperglycemia following intensive insulin therapy in newly diagnosed type 2 diabetic patients: a long-term follow-up study.
Xu W; Li YB; Deng WP; Hao YT; Weng JP
Chin Med J (Engl); 2009 Nov; 122(21):2554-9. PubMed ID: 19951569
[TBL] [Abstract][Full Text] [Related]
8. The response to short-term intensive insulin therapy in type 2 diabetes.
Retnakaran R; Yakubovich N; Qi Y; Opsteen C; Zinman B
Diabetes Obes Metab; 2010 Jan; 12(1):65-71. PubMed ID: 19740080
[TBL] [Abstract][Full Text] [Related]
9. Fasting plasma glucose after intensive insulin therapy predicted long-term glycemic control in newly diagnosed type 2 diabetic patients.
Liu J; Liu J; Fang D; Liu L; Huang Z; Wan X; Cao X; Li Y
Endocr J; 2013; 60(6):725-32. PubMed ID: 23428844
[TBL] [Abstract][Full Text] [Related]
10. Effect of short-term intensive insulin therapy on the incretin response in early type 2 diabetes.
Choi H; Kramer CK; Zinman B; Connelly PW; Retnakaran R
Diabetes Metab; 2019 Apr; 45(2):197-200. PubMed ID: 29395808
[TBL] [Abstract][Full Text] [Related]
11. Teneligliptin improves glycemic control with the reduction of postprandial insulin requirement in Japanese diabetic patients.
Tsuchimochi W; Ueno H; Yamashita E; Tsubouchi C; Sakoda H; Nakamura S; Nakazato M
Endocr J; 2015; 62(1):13-20. PubMed ID: 25252844
[TBL] [Abstract][Full Text] [Related]
12. Glucagon-like peptide-1 augments insulin-mediated glucose uptake in the obese state.
Egan JM; Meneilly GS; Habener JF; Elahi D
J Clin Endocrinol Metab; 2002 Aug; 87(8):3768-73. PubMed ID: 12161508
[TBL] [Abstract][Full Text] [Related]
13. C-peptide response to glucagon in type 2 diabetes mellitus: a comparison with oral glucose tolerance test.
Iwasaki Y; Kondo K; Hasegawa H; Oiso Y
Diabetes Res; 1994; 25(3):129-37. PubMed ID: 7671552
[TBL] [Abstract][Full Text] [Related]
14. Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis.
Kramer CK; Zinman B; Retnakaran R
Lancet Diabetes Endocrinol; 2013 Sep; 1(1):28-34. PubMed ID: 24622264
[TBL] [Abstract][Full Text] [Related]
15. [The effect and mechanism of transient continuous subcutaneous insulin infusion therapy on beta cell function, insulin resistance and vascular endothelial injury in newly diagnosed type 2 diabetes].
Liu SP; Mo H; Liu BL; Tang WL; Deng XG; Su X; Yao L; Lin J; Feng Q; Peng J; Zhou ZG; Li YJ
Zhonghua Nei Ke Za Zhi; 2010 May; 49(5):405-9. PubMed ID: 20646415
[TBL] [Abstract][Full Text] [Related]
16. [The effects of early intensive therapy on islet beta cell function and long-term glycemia control in newly diagnosed type 2 diabetic patients with different fasting plasma glucose levels.].
Li YB; Zeng LY; Shi LX; Zhu DL; Zhou ZG; Yan L; Tian HM; Luo ZJ; Yang LY; Liu J; Weng JP
Zhonghua Nei Ke Za Zhi; 2010 Jan; 49(1):9-13. PubMed ID: 20356473
[TBL] [Abstract][Full Text] [Related]
17. Effect of linagliptin compared with glimepiride on postprandial glucose metabolism, islet cell function and vascular function parameters in patients with type 2 diabetes mellitus receiving ongoing metformin treatment.
Forst T; Anastassiadis E; Diessel S; Löffler A; Pfützner A
Diabetes Metab Res Rev; 2014 Oct; 30(7):582-9. PubMed ID: 24459063
[TBL] [Abstract][Full Text] [Related]
18. Subcutaneous glucagon-like peptide-1 improves postprandial glycaemic control over a 3-week period in patients with early type 2 diabetes.
Todd JF; Edwards CM; Ghatei MA; Mather HM; Bloom SR
Clin Sci (Lond); 1998 Sep; 95(3):325-9. PubMed ID: 9730852
[TBL] [Abstract][Full Text] [Related]
19. Overnight normalization of glucose concentrations improves hepatic but not extrahepatic insulin action in subjects with type 2 diabetes mellitus.
Wise SD; Nielsen MF; Cryer PE; Rizza RA
J Clin Endocrinol Metab; 1998 Jul; 83(7):2461-9. PubMed ID: 9661629
[TBL] [Abstract][Full Text] [Related]
20. Impact of glucagon response on postprandial hyperglycemia in men with impaired glucose tolerance and type 2 diabetes mellitus.
Henkel E; Menschikowski M; Koehler C; Leonhardt W; Hanefeld M
Metabolism; 2005 Sep; 54(9):1168-73. PubMed ID: 16125528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
